Institutional investment that wants in on the cannabis sector has no chocie currently but to invest in Canadian LPs.
While re-scheduling and SAFE don't legalize cannabis in the US - it's common sense that the restrictions that currently apply to US MSOs will at least easeup. That mean access to financial services from banks, listing on senior exchanges - and institutional investment.
With the US already the largest cannabis amrket in the world - and Canadian companies still not allowed to sell recreational cannabis in the country, you'll see those same institutions that want to be in cannabis, move out of the dead Canadian LPS and into the US MSOs whose opportunties will sky rocket
No-one wants to validate your opinions quinlash, no-one cares what a narcissist, paid promoter posts with his misleading, inaccuaret and incorrect opinions.
Post by
quinlashon Jun 15, 2024 11:17pm ![](https://assets.stockhouse.com/kentico-cms/0338-00/images/Sprite.svg#id_Post_Views_Icon)
154 Views
Post# 36090910
RE:Is there anyone who DOESN'T think
....that there is not one single institutional or major US player who will be looking for first mover advantage on something as significant as the rescheduling of cannabis in the United States of America ???
I have my views on the subject. I am certainly not asking anyone to validate my opinions however I would suggest all give it some thought.